Fosun International Ltd

Q4 2017 13F Holdings Report, Stock Holdings

Signature - Title
Angel Sze - Company Secretary
Location
Hong Kong, China
Holdings as of
31 Dec 2017
Value $
$1,140,498,000
Num holdings
61
Filing time
09 Feb 2018, 06:07:33 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included SFUN, SINA, KANG, IPXL, and VRAYQ.
Previous filing
Q3 2017 - 14 Nov 2017
Next filing
Q1 2018 - 08 May 2018
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2017 Q4 compared to 2017 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Angel Sze Company Secretary Hong Kong, Hong Kong 09 Feb 2018

Other Included Managers (2):

Num Name Location File Number
1 Fidelidade-Companhia de Seguros, S.A. Lisboa 028-16288
2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Shanghai, China